Investigational Drug Details
| Drug ID: | D425 |
| Drug Name: | Buformin |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB04830 |
| DrugBank Description: | Buformin is an anti-diabetic drug of the biguanide class, chemically related to metformin and phenformin. It was withdrawn from the market in most countries due to a high risk of causing lactic acidosis. |
| PubChem ID: | 2468 |
| CasNo: | 692-13-7 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CCCC\N=C(/N)N=C(N)N |
| Structure: |
|
| InChiKey: | XSEUMFJMFFMCIU-UHFFFAOYSA-N |
| Molecular Weight: | 157.2168 |
| DrugBank Targets: | |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|